These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11109284)

  • 1. [[Chronic renal allograft rejection. Part 2. Therapeutic possibilities] ].
    Viklický O; Matl I; Lácha J; Muller V; Szabo A; Heemann UW
    Cas Lek Cesk; 2000 Aug; 139(17):524-8. PubMed ID: 11109284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring treatment options in renal transplantation: the problems of chronic allograft dysfunction and drug-related nephrotoxicity.
    Campistol JM; Grinyó JM
    Transplantation; 2001 Jun; 71(11 Suppl):SS42-51. PubMed ID: 11583488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New strategies for the treatment of chronic rejection.
    Hoerbelt R; Muniappan A; Madsen JC; Allan JS
    Curr Opin Investig Drugs; 2004 May; 5(5):489-98. PubMed ID: 15202721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
    Waid T;
    Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors.
    Kreis HA; Ponticelli C
    Transplantation; 2001 Jun; 71(11 Suppl):SS5-9. PubMed ID: 11583489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential therapeutic interventions to avoid or treat chronic allograft dysfunction.
    Kahan BD
    Transplantation; 2001 Jun; 71(11 Suppl):SS52-7. PubMed ID: 11583490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Causes of late renal transplant dysfunction].
    Szabó A; Müller V
    Orv Hetil; 2002 Dec; 143(51):2811-9. PubMed ID: 12638307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of renal allograft fibrosis.
    Waller JR; Nicholson ML
    Br J Surg; 2001 Nov; 88(11):1429-41. PubMed ID: 11683737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
    Jevnikar A; Arlen D; Barrett B; Boucher A; Cardella C; Cockfield SM; Rush D; Paraskevas S; Shapiro J; Shoker A; Yilmaz S; Zaltzman JS; Kiberd B
    Transplantation; 2008 Oct; 86(7):953-60. PubMed ID: 18852662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of chronic renal allograft dysfunction].
    Morozumi K; Takeda A; Uchida K
    Hinyokika Kiyo; 2002 Nov; 48(11):673-7. PubMed ID: 12512140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic rejection: pathogenesis and treatment.
    Lee HM
    Transplant Proc; 1996 Jun; 28(3):1146-7. PubMed ID: 8658602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year results of kidney transplantation under tacrolimus-based regimes: the persisting significance of vascular rejection.
    Loucaidou M; McLean AG; Cairns TD; Griffith M; Hakim N; Palmer A; Papalois V; Van Tromp J; Loucaides C; Welsh KI; Taube D
    Transplantation; 2003 Oct; 76(7):1120-3. PubMed ID: 14557763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney transplantation: graft monitoring and immunosuppression.
    Fisher JS; Woodle ES; Thistlethwaite JR
    World J Surg; 2002 Feb; 26(2):185-93. PubMed ID: 11865349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic rejection of renal allografts. Part 1. Present knowledge of etiopathogenesis].
    Viklický O; Matl I; Heemann UW
    Cas Lek Cesk; 1999 Nov; 138(23):711-5. PubMed ID: 10746033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rapamycin: a new immunosuppressive agent capable of inhibiting chronic rejection?].
    Viklický O; Matl I
    Cas Lek Cesk; 2001 Jan; 140(1):22-5. PubMed ID: 11242980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure.
    He X; Johnston A
    Transplant Proc; 2004 Dec; 36(10):2993-6. PubMed ID: 15686679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.